Gallery Photos
GLP-1 receptor agonists as an adjunct to bariatric surgery for weight ...
GLP-1analogues have been used as adjunct therapies tobariatricsurgery, either preoperatively or postoperatively. Liraglutide and semaglutide have demonstrated 15-17%weightloss, along with cardiometabolic protective properties [6].
GLP-1 receptor agonists as an adjunct to bariatric surgery for weight ...
Oct 10, 2025Tirzepatide, a newer GLP-1/GIP agonist, showed even greaterweightlosscompared to semaglutide over 6 months. A systematic review of 6 studies on the metabolic effects ofGLP-1receptor agonists (RA) post-bariatricsurgeryhighlighted significant improvements in glycemic control, blood pressure, cholesterol levels, and liver function.
Bariatric Surgery vs. GLP-1s: Comparing Weight Loss Treatments
Obesity is a complex condition with many causes, including genetics, environmental factors, medications and lifestyle choices. Many people struggle for years to loseweightandkeep it off.Bariatricsurgeryandmedications calledGLP-1s(glucagon-like peptide-1 receptor agonists) are popular ...
GLP-1 drugs versus bariatric surgery for treating obesity
GLP-1drugs andbariatricsurgerycan both treat obesity. Learn how they compare onweightloss, health benefits, risks, and when combining approaches may help.
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
Sep 17, 2025This cohort study uses a large US insurance claims database to assessweightlossandongoing costs associated with metabolicbariatricsurgeryvs glucagon-like peptide-1 receptor agonists.
One in Seven Bariatric Surgery Patients Turn to New Weight Loss Drugs
Aug 27, 2025Bariatricsurgeryis usually effective on its own forweightloss, but an increasing proportion of patients who undergobariatricsurgerystart taking one of the new glucagon-like1peptide receptor agonist (GLP-1)weight-lossdrugs in the years after theirsurgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers analyzed de ...
Bariatric Surgery vs. GLP-1 Medications: What the Latest Research Shows ...
WhileGLP-1drugs continue to play a role in obesity treatment, this study reinforces thatbariatricsurgeryremains the most effective and durable option for significant, long-termweightloss.
Using GLP-1s for weight loss, maintenance after bariatric surgery
Mar 5, 2026Bariatricsurgeryhas become a cornerstone treatment for severe obesity and its related comorbidities, offering superior long-term efficacy compared with lifestyle and pharmacologic interventions alone. Yet persistent clinical gaps remain in a subset of patients, including insufficientweightlossandpostoperativeweightregain.
GLP-1s for Weight Loss and Maintenance Post-Bariatric Surgery
Mar 4, 2026The clinical implications ofGLP-1use to manageweightregain afterbariatricsurgery. How to guide patients.
GLP-1 and Bariatric Surgery: Lasting Weight Loss Results
Feb 28, 2025Conclusion Combining medicalweightlossandbariatricsurgeryoffers a promising approach for individuals seeking durableweightloss. By integratingGLP-1receptor agonists, lifestyle intervention, andbariatricprocedures, patients can achieve better outcomes and improved long-termweightmanagement.
GLP-1 vs Bariatric Surgery: Comparing Weight Loss Options for 2025
BothGLP-1medications andbariatricsurgeryrepresent proven medical interventions for seriousweightloss, but they differ dramatically in approach, timeline, and long-term commitment requirements. Understanding these differences helps patients make informed decisions about theirweightmanagement journey.
Cincinnati Weight Loss Clinic | Bariatric & Medical Weight Loss
JourneyLite's Cincinnatiweightlossclinic offers gastric sleeve, gastric bypass, revisionsurgery, gastric balloon, and medicalweightlossoptions for patients in Ohio, Kentucky, and Indiana.
Bariatric Surgery After GLP-1s: When to Switch & Eligibility
3 days agoCompareweightlossresults, costs, and health benefits ofGLP-1medications vs.surgery. Expert guidance on transitioning from medical to surgicalweightloss.
FDA HighestâYet Dose of Semaglutide, GLPâ1s Grows - SurvivorNet
4 days agoWeightlossof more than 10%âwhether throughbariatricsurgery(procedures that reduce stomach size) orGLPâ1medications like Wegovy or Ozempicâhas been linked to modest reductions in obesityârelated cancer risk, according to a new study released in JAMA.
GLP-1 and Muscle Loss: How to Preserve Lean Mass During Weight Loss
7 days agoThe key question is how to minimize it. What Does the Research Say AboutGLP-1andLean Body Mass? Current evidence suggests that approximately 25 to 40 percent ofweightlossonGLP-1medications may come from lean body mass. However, this proportion is similar to what is seen afterbariatricsurgeryor major caloric restriction.
GLP-1 Medications Patient Guide | Dr. Yi - orderlymeds.com
Jun 18, 2025Abariatricsurgeon's guide toGLP-1medications â how they work, what to expect, protein rules, side effects, and common questions answered.
Pharmacologic Strategies for Weight Regain Post-Bariatric Surgery
5 days agoDiscussion and Conclusion: Despite the Common Use ofGLP-1Therapy in Post-BariatricSurgery, Direct Comparative Evidence in Postoperative Populations Remains Sparse The review frames insufficientweightlossandweightregain as predictable postoperative challenges that often need long-term management.
Are GLP-1s everything we hoped for? - Mayo Clinic Press
5 days agoGLP-1s, one year later: Mayo Clinic experts discuss how theseweight-lossanddiabetes drugs work, changing access and costs, side effects, and what's next.
GLP-1 Diet: Foods to Eat and Foods to Avoid - ibihealthcare.com
3 days agoMaster yourGLP-1Diet with our guide on foods to eat and avoid. Optimize yourweightlossjourney with expert tips from IBI Clinic today.
Why does weight loss stall on GLP-1 medications?
1 day agoFor those not achieving desiredweightloss, medication dose adjustments, switchingGLP-1medications, or consideringbariatricsurgerymay be beneficial. Regular monitoring of progress, mental health support, and setting long-term health goals are essential for sustainableweightloss.
Cost, Side Effects Top Reasons for Quitting GLP-1s
6 days agoAnd, as we described in our earlier research, once you stop, the outcomes are unlikely to be the same as those reported from randomized clinical trials where on average patients achieve 15% to 20%weightloss." A path cut bybariatricsurgery
AZ Weight Loss Surgery | What Happens If GLP-1 Doesn't Work? Here's ...
3 days agoWeightloss:GLP-1medications produce meaningfulweightlossin patients who respond, but the magnitude is typically smaller than whatsurgeryproduces. In the ASMBS 2025 study, the difference was substantial.
Sharon Osbourne's Weight Loss Journey: From Bariatric Surgery to Atkins ...
Mar 26, 2025Here, we take a look at herweightlossjourney, including what worked and what didn't. The start of Sharon Osbourne's 100-lb.weightlossefforts Osbourne has been outspoken about struggling to manage herweight,andeven before the era ofweightlossmedications, she went public with what she's tried to slim down.
Medical Weight Loss Is Changing - torrancememorial.org
7 days agoMedicalweightlosshas evolved. Learn howGLP-1medications,bariatricsurgery, nutrition counseling and personalized care help patients achieve safe, sustainableweightloss.
Metabolic Bariatric Surgery versus GLP-1 Receptor Agonists for Obesity ...
Introduction: Metabolic andbariatricsurgery(MBS) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are both effective strategies for obesity management, but their comparative efficacy remains uncertain. This systematic review and meta-analysis aimed to compareweightlossoutcomes between MBS andGLP-1RA therapy in adults with obesity.
New analysis of GLP-1 drugs suggests people who stopped using ...
Mar 5, 2026A new study, recently shared on Good Morning America, on life afterweightlossdrugs examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popularGLP-1medications. For people who stopped takingGLP-1weight-lossmedications, patients regained about 60% of theweight[âŚ]
AAPS - Massive Weight Loss With Bariatric Surgery And GLP-1 Receptor ...
MassiveWeightLossWithBariatricSurgeryAndGLP-1Receptor Agonist Therapy Predicts Postoperative Complications Following Abdominal Body ContouringSurgeryJoey Liang, BS1, Jackson M. Cathey, BS1, Liban Mohamed, BS1, Victoria N. Yi, MD2, Brooke E. Barrow, MD, MEng2, Detlev Erdmann, MD, PhD, MHSc2, Ash Patel, MB ChB2. 1Duke University School of Medicine, Durham, NC, USA, 2Division of Plastic ...
Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor ...
Mar 4, 2026This cross-sectional analysis examines trends through 2025 in the use of metabolic andbariatricsurgeryduring a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.
TrimRX | GLP-1 Medications and Bone Health: What to Know
3 days agoThe Overall AssessmentGLP-1medications are not bone-toxic drugs. The modest reductions in bone mineral density seen during treatment are consistent withweightlossphysiology broadly, appear smaller than what's observed withbariatricsurgery,andhaven't translated to clearly elevated fracture rates in trial populations to date.